SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-279829
Filing Date
2015-08-06
Accepted
2015-08-06 07:00:58
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d51192d10q.htm 10-Q 593145
2 EX-10.1 d51192dex101.htm EX-10.1 364140
3 EX-10.2 d51192dex102.htm EX-10.2 63303
4 EX-10.3 d51192dex103.htm EX-10.3 39569
5 EX-31.1 d51192dex311.htm EX-31.1 6491
6 EX-31.2 d51192dex312.htm EX-31.2 6465
7 EX-32.1 d51192dex321.htm EX-32.1 4067
8 EX-32.2 d51192dex322.htm EX-32.2 4046
  Complete submission text file 0001193125-15-279829.txt   3227513

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT srpt-20150630.xml EX-101.INS 468697
10 XBRL TAXONOMY EXTENSION SCHEMA srpt-20150630.xsd EX-101.SCH 31597
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20150630_cal.xml EX-101.CAL 55919
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20150630_def.xml EX-101.DEF 73453
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20150630_lab.xml EX-101.LAB 241993
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20150630_pre.xml EX-101.PRE 174641
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 151031050
SIC: 2834 Pharmaceutical Preparations